0973-27-25_Request For Proposal_San Luis Obispo County.pdf

BPA-Solicitation Number: 0973-27-25 Page A- 1 of 1

✎AO 367

(Rev. 3/24)

SECTION A SOLICITATION / OFFER / ACCEPTANCE

1. Solicitation No. 2. Date Issued 3. Award No.

0973-27-25 07/20/2026

4. Issued By: 5. E-mail Address Offer To (if other than Item 4):

Erik Cisneros «A_F_recipientName» erik_cisneros@cacd.uscourts.gov

SOLICITATION

6. Proposals for furnishing the required services listed in Section B will be received electronically via the e-mail address(es) specified in Item 4 or 5 until 04:00 PM local time 08/20/2026 (hour) (date)

7. For Information call:

a. Name Jeannette Gonzalez b. Telephone (626) 960-0327

TABLE OF CONTENTS

(X) SEC. DESCRIPTION PAGE(S) (X) SEC. DESCRIPTION PAGE(S)

PART I – THE SCHEDULE PART II – AGREEMENT CLAUSES

X A SOLICITATION/OFFER/ACCEPTANCE 1 X I REQUIRED CLAUSES 13

X B SUPPLIES OR SERVICES AND PRICES/COSTS 6 PART III – LIST OF DOCUMENTS, EXHIBITS AND OTHER ATTACH.

X C DESCRIPTION/SPECS./WORK STATEMENT 39 X J LIST OF ATTACHMENTS «A_FP_SecJ»

X D PACKAGING AND MARKING 1 PART IV – REPRESENTATIONS AND INSTRUCTIONS

X E INSPECTION AND ACCEPTANCE 1

X K

REPRESENTATIONS, CERTIFICATIONS AND

OTHER STATEMENTS OR OFFERORS 2

X F DELIVERIES OR PERFORMANCE 1

X G AGREEMENT ADMINISTRATION DATA 3 X L INSTRS., CONDS., AND NOTICES TO OFFERORS 15

X H SPECIAL AGREEMENT REQUIREMENTS 4 X M EVALUATION CRITERIA 6

OFFER

8. In compliance with the above, the undersigned agrees, if this offer is accepted within _____________calendar days (365 calendar days unless a different period is inserted by the offeror) from the date for receipt of offers specified above, to furnish any or all items upon which prices are offered at the price set opposite each item, delivered at the designated point(s), within the time specified in the schedule.

9. DISCOUNT FOR PROMPT PAYMENT 10 CALENDAR DAYS 20 CALENDAR DAYS 30 CALENDAR DAYS CALENDAR DAYS (See Section I, Clause No. 52-232-8) % % % %

10. ACKNOWLEDGEMENT OF AMENDMENTS

(The offeror acknowledges receipt of amend-ments to the SOLICITATION for offerors and related documents numbered and dated:

AMENDMENT NO. DATE AMENDMENT NO. DATE

11. NAME 16. AWARD

AND

ADDRESS Your offer on Solicitation Number , including the OF additions or changes made by you which additions or changes are set forth in full above, is hereby accepted as to the items listed above and on any continuation sheets.OFFEROR

12. Telephone No. (Include area code)

13. NAME AND TITLE OF PERSON AUTHORIZED TO SIGN OFFER 17A. NAME OF CONTRACTING OFFICER (Type or print)

17B. UNITED STATES OF AMERICA 17C. DATE SIGNED

14. Signature 15. Offer Date BY (Signature Of Contracting Officer)

BPA-Solicitation Number: 0973-27-25 Page B- 1 of 6

Revised FY 2027

SECTION B - SUPPLIES OR SERVICES AND OFFEROR'S PRICES

The United States District Court for the Central District of California is soliciting a vendor to provide substance use, mental health, and/or sex offender treatment services. A vendor must be capable of providing services within a geographic area encompassing San Luis Obispo County.

As a result of this solicitation the Government intends to enter into a Blanket Purchase Agreement (BPA). For this BPA, approximately 1 to 2 vendors are needed to provide the required services. The Government reserves the right to award to a single vendor. If the Government awards to more than one vendor, each vendor placed on the BPA will receive a share of the total quantity of Estimated Monthly Quantities stated.

A Blanket Purchase Agreement is a “charge account” arrangement, between a buyer and a seller for recurring purchases of services. BPAs are not contracts and do not obligate government funds in any way. A contract occurs upon the placement of a call or referral from the Probation/Pretrial Services Office and the vendor’s acceptance of the referral. In the event the Government has awarded to more than one vendor on a BPA, referrals will be rotated among all the vendors on the BPA. BPAs are valid for a specific period of time, not to extend beyond the current fiscal year. The total duration of this BPA, including the exercise of four 12-month options, shall not exceed 60 months. BPAs will be issued to those vendors determined to be technically acceptable and offering the lowest cost to the Government, using the Evaluation Criteria established in Section M of the Request for Proposal.

Section B is generic and used nationwide to procure the particular needs of each U. S. Probation/Pretrial Services Office. An asterisk * indicates a requirement line item which has been modified under “Local Services.” Offerors shall submit pricing and proposal information related to only the required services. Services proposed, but not required, will not be evaluated or included under any resultant agreement. Offerors failing to provide pricing on all identified project codes (with the exception of actual cost or administrative fees), will be considered technically unacceptable.

Note: the fiscal year for the federal Government begins on October 1 of one calendar year through September 30 of the next. Pricing shall include the base fiscal year, as well as pricing for each fiscal option year.

Note: Estimated Monthly Quantities (EMQs) represent the estimated total monthly quantities to be ordered per project code. However, EMQ’s are estimates only and do not bind the government to meet these estimates.

BPA-Solicitation Number: 0973-27-25 Page B- 2 of 6

DRUG TESTING:

PROJECT

CODE

REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT

PRICE

X * 1010 Urine Collection Base Year

Option Year 1

Option Year2

Option Year3

Option Year4

Unit: Price: per specimen

PROJECT

CODE

REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT

PRICE

X 1012 Sweat Patch/Application and Removal

Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: Price: per patch (at removal)

PROJECT

CODE

REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT

PRICE

X * 1504 Breathalyzer Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per administration

SUBSTANCE USE SERVICES :

BPA-Solicitation Number: 0973-27-25 Page B- 3 of 6

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 2000 Case Management Services (Substance

Use) Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per 30-minute session

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 2011 Substance Use Assessment Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per report

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 2022 Manualized Cognitive Behavioral Group Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per 30-minute session

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 2010 Substance Use Individual Counseling Base Year

Option Year 1

Option Year 2

Option Year 3

BPA-Solicitation Number: 0973-27-25 Page B- 4 of 6

Option Year 4 13

Unit: per 30-minute session

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 2020 Substance Use Group Counseling Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per 30-minute session

CO-OCCURRING DISORDERS SERVICES:

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X * 6015 Co-Occurring Disorders Individual Counseling

Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per 30-minute session

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X 6026 Co-Occurring Disorders Group Counseling Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unit: per 30-minute session

TRANSPORTATION EXPENSE:

BPA-Solicitation Number: 0973-27-25 Page B- 5 of 6

X 1201 Administrative Fee Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unknown

Unknown

Unknown

Unknown

Unknown

Unit: unknown

5% of amount distributed under pc 1202

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X 1202 Transportation Expenses Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unknown

Unknown

Unknown

Unknown

Unknown

Unit: unknown

Actual cost

VENDOR'S LOCAL TRAVEL:

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X 1401 Vendor’s Local Travel by Vehicle Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unknown

Unknown

Unknown

Unknown

Unknown

Unit: unknown

Actual cost

BPA-Solicitation Number: 0973-27-25 Page B- 6 of 6

X 1402 Vendor’s Local Travel by Common Carrier Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unknown

Unknown

Unknown

Unknown

Unknown

Unit: unknown

Actual cost

REIMBURSEMENT/COPAYMENT:

PROJECT CODE REQUIRED SERVICES ESTIMATED MONTHLY QUANTITY UNIT PRICE

X 1501 Administrative Fee Base Year

Option Year 1

Option Year 2

Option Year 3

Option Year 4

Unknown

Unknown

Unknown

Unknown

Unknown

Unit: unknown

5% of fees collected by vendor

BPA-Solicitation Number: 0973-27-25 Page C- 1 of 40

Revised FY 2027

SECTION C. DESCRIPTION/STATEMENT OF WORK

PROVISION OF SERVICES

The United States Probation and Pretrial Services Office (hereafter USPO/USPSO) shall provide a Probation Form 45 for each defendant/person under supervision that authorizes the provision of services. The vendor shall provide services strictly in accordance with the Probation Form 45 for each defendant/person under supervision. The Judiciary shall not be liable for any services provided by the vendor that have not been authorized for that defendant/person under supervision on the Probation Form 45. During treatment, the United States Probation or Pretrial Services Officer may issue amended Probation Form 45’s to reflect any changes in the service requirements. The USPO/USPSO will notify the vendor in writing via Probation Form 45 when services are to be terminated. The Judiciary shall not be liable for any services provided by the vendor subsequent to the written notification.

INTRODUCTION

A. Pursuant to the authority contained in 18 U.S.C. §§ 3154 and 3672, contracts or Blanket Purchase Agreements may be awarded to provide services for defendants/persons under supervision who are drug-dependent, alcohol-dependent, and/or suffering from a psychiatric disorder. Such services may be provided to federal defendants/persons under supervision supervised by the USPO/USPSO, under the terms of this agreement. The vendor shall submit separate invoices for services provided to the referring agency (USPO or

USPSO).

Note regarding pretrial services defendants: The vendor shall not ask questions pertaining to the instant offense (pending charges) or ask questions or administer tests that compel the defendant to make incriminating statements or provide information that could be used in the issue of guilt or innocence. If such information is divulged as part of an evaluation or treatment, it shall not be included in the written report.

B. The services to be performed are specified in Sections B and C of this agreement.

The vendor shall comply with all requirements and performance standards of this agreement to ensure the effective and efficient delivery of services. The vendor is responsible for their knowledge of the agreement and shall adhere to these standards to maintain the quality and integrity of the authorized services.

C. The judiciary will refer defendants/persons under supervision on an “as needed basis.” The judiciary does not guarantee referrals for a specific quantity of services or a specific number of persons.

BPA-Solicitation Number: 0973-27-25 Page C- 2 of 40

DEFINITIONS

A. “Judiciary” means United States Government.

B. “Authorized representative” means any person, persons, or board (other than the contracting officer and Chief Probation Officer/Chief Pretrial Services Officer) authorized to act for the head of the agency.

C. “Contracting Officer” (i.e. CO) means the duly authorized representative to execute this Agreement on the behalf of the Judiciary, and any other successor Contracting Officer who has responsibility for this agreement. The term includes, except as otherwise provided in this Agreement, the authorized representative of a Contracting Officer acting within the limits of their written authority.

D. “Defendant/Person Under Supervision” means any pretrial releasee, probationer, parolee, mandatory releasee, mandatory parolee, or supervised releasee receiving drug/alcohol testing and/or substance use assessment/treatment, mental health assessment/evaluation/treatment, and or sex offense specific evaluation/treatment/testing while under the supervision of the Federal Probation or Pretrial Services Office. Hereinafter, the term defendant applies to those on pretrial supervision, whereas person under supervision applies to those on post-conviction supervision.

E. “U.S. Probation Officer” (i.e., USPO) and “U.S. Pretrial Services Officer” (i.e., USPSO) means an individual appointed by the United States District Court to provide pretrial, presentence and supervision (pre and post sentence) services for the court. USPO and USPSO refers to the individual responsible for the direct supervision of a defendant/person under supervision receiving drug/alcohol testing and/or substance use assessment/treatment, mental health assessment/evaluation/treatment, sex offense specific evaluation/treatment/testing, and/or specialized treatment for pretrial defendants charged with a sex offense.

F. “Designee” means the person selected by the Chief Probation Officer or the Chief Pretrial Services Officer to act in their behalf in drug, alcohol, and mental health treatment matters.

G. “Telehealth” includes providing health care delivery, assessment, diagnosis, consultation, and treatment and the transfer of medical data through interactive audio, video, or electronic/data communications.

H. “Clarifications” are limited exchanges, between the Judiciary and offerors that may occur when award without discussions is contemplated. If award will be made without conducting discussions, offerors may be given the opportunity to clarify certain aspects of proposals or to resolve minor or clerical errors.

I. “AOUSC” refers to the Administrative Office of the U.S. Courts.

J. “Probation Form 45" is the referring document submitted by the USPO/USPSO per defendant/person under supervision that outlines only those services the vendor is authorized to provide and invoice to the Judiciary. It should be noted the Probation Form 45 only requires the signature of the referral agent.

K. “Monthly Sign-In Log” is a document the vendor will use for each defendant/person under supervision to verify services are being offered/provided per Probation Form 45 requirements. The Monthly Sign In Log includes a place for defendant/person under supervision to sign for services based on project code, with a time in/out, vendor initials, co-payment received, and comments (to

BPA-Solicitation Number: 0973-27-25 Page C- 3 of 40 include a comment if the defendant/person under supervision failed to report, if no services were provided/received within the month, and if telehealth was provided including the means in which the session was provided (teleconference, video conference, internet). This document accompanies the monthly invoice.

L. “Case Staffing Conference” is a collaborative meeting involving the officer, the vendor, and when possible, the defendant/person under supervision, to exchange information, identify issues, and ensure the purpose of services is focused on targeting the identified risk and needs of the individual.

M. “DSM” is the Diagnostic and Statistical Manual of Mental Disorders and “ICD” is the International Classification of Diseases.

N. “Co-payment” is any payment from defendant/person under supervision.

O. “AMO” is the Acquisition Management Office at the Administrative Office of the U.S. Courts.

P. “PCRA” means the Post-Conviction Risk Assessment, which is an assessment administered by the USPO with the person under supervision used to determine risk level, identify dynamic risk factors (criminogenic needs) and criminal thinking styles. A copy of the PCRA interpretation report with the identified risk level should be provided to the treatment vendor with the referral for services.

Q. “Criminogenic Risk” includes factors in a person under supervision’s life that are directly related to recidivism. The most significant are Cognitions, Alcohol and Drugs, Employment/Education, Social Networks and Criminal History.

R. “PTRA” means the Pretrial Risk Assessment, which is an assessment administered by the USPSO with the defendant used to determine failure to appear and new criminal arrests or revocations due to technical violations.

MANDATORY REQUIREMENTS

For Project Codes in Section B, the corresponding paragraphs in this statement of work shall be considered mandatory requirements, as well as the sections listed below:

A. Defendant/Person under supervision Reimbursement and Co-payment B. General Requirements C. Notifying USPO/USPSO of Defendant/Person under Supervision

Behavior D. Staff Requirements and Restrictions E. Facility Requirements F. Local Services (if applicable)

DRUG TESTING

1. Urine Collection (1010)

The vendor shall perform the following procedures related to the collection of urine specimens. The Designee will provide the vendor with the necessary urinalysis collection materials (i.e. Chain of Custody forms, vials, specimen bags, mailing boxes, BPA-Solicitation Number: 0973-27-25 Page C- 4 of 40 mailing labels which include the cost of shipping); however, the vendor is responsible for printer ink, disposable gloves, cleaning agents, coloring agent, etc.

a. Storage of Urinalysis Supplies

The vendor shall:

(1) Store all urinalysis supplies in a secure area with access limited only to authorized vendor employees involved in the collection process.

b. Secure Collection Area

The vendor shall:

(1) To the extent possible, provide a lavatory only for collecting urine specimens that is not used by staff or others not providing urine specimens.

(2) If the lavatory is used by others not providing a urine specimen, the vendor shall:

(a) Limit the possibility of any interference with the collection process or adulteration of the specimen; and

(b) Limit access during the collection process to only those involved in the collection of urine specimens.

c. Safety Precautions and Collector Training

(1) The vendor shall ensure that collectors reviewed and acknowledged the federal OSHA Bloodborne Pathogen regulations (29 C.F.R. 1910.1030). The vendor shall document the same in the collector’s personnel file and the collector must certify they have received and understand the regulations. The vendor shall provide the documentation to the CO upon request.

(2) The vendor shall ensure that all personnel handling urine specimens wear disposable gloves designed for protection against biohazards and are familiar with standard precautions for handling bodily fluids.

(3) The vendor shall ensure collector training includes fostering respectful and appropriate interactions with defendants/persons under supervision regardless of gender, race, ethnicity, religion, cultural background, sexual orientation, or other personal characteristics.

BPA-Solicitation Number: 0973-27-25 Page C- 5 of 40

d. General Urine Specimen Collection Procedures

(1) The vendor shall ensure defendants/persons under supervision:

(a) Remove jackets, coats, and large pocket items before entering the collection area. These items can be placed on a hook or table inside the collection area.

(b) Set aside purse or other carried items. These items can remain in the collection areas; however, must remain outside of immediate access from the defendant/person under supervision.

(c) Vigorously wash their hands using soap and water, then thoroughly rinse their hands to remove all soap and any adulterants from under the fingernails or on the skin, and finally dry their hands completely prior to voiding.

(d) Roll up long-sleeved shirts so the collector can examine defendant’s/person under supervision’s arms to detect tampering devices or adulterants.

(2) The vendor shall ensure that the collectors:

(a) Verify the identity of the defendant/person under supervision by means of a state driver’s license, state identification or other acceptable form of photo identification.

(b) Collect specimens from only one donor at a time. Both the donor and the collector shall keep the specimen collection container in view at all times prior to it being sealed and labeled.

(c) Complete a Chain of Custody (provided by the Designee) before a defendant/person under supervision voids following the chain of custody procedures and peel the Barcode label from the Chain of Custody form and place it on the bottle.

(d) Collect a minimum of 30 milliliters of urine to allow the laboratory to conduct the initial presumptive screen and confirmation tests. A specimen with less than 10 milliliters of urine is not acceptable for testing and shall not be submitted, unless specifically authorized by the Probation or Pretrial Services Office, as the nationally contracted laboratory will not test it due to insufficient quantity.

(e) Not flush urinals/commode until the collection is completed and the collector advises it is safe to do so (a coloring agent is not necessary for direct observation of urine collection).

(f) Observe and document any indication (unusual color, odor) of specimen dilution and/or adulteration, or any unusual

BPA-Solicitation Number: 0973-27-25 Page C- 6 of 40 collection events or discrepancies.

(g) Close and tightly secure the specimen collection container, to ensure it will not leak. The collector shall ensure the container is tightly secured.

(h) Review the temperature of the specimen to determine if it is near body temperature, if applicable. If temperatures strips are provided by the Designee, the temperature of the specimen should be measured within 4 minutes of collection and should be within a range of 90 - 100 degrees.

(i) Use tamper evident tape or label across the top of the bottle cap and down the sides of the bottle, and the collector or defendant/person under supervision shall initial the tamper tape or label.

(j) Sign the Specimen Collection Statement of the Chain of Custody Form. The collector shall not sign the certification area of the form until the collection process is completed.

(k) Have the defendant/person under supervision sign the Chain of Custody Form after the collection process is completed.

(l) Follow notification protocols outlined in this Statement of Work under Notifying USPO/USPSO of Defendant/Person Under Supervision Behavior.

e. Observed Urine Specimen Collection Procedures

The vendor shall:

(1) Directly observe defendants/persons under supervision voiding into a specimen collection container. Collectors conducting direct observation of urine collection shall be the same gender as the defendant/person under supervision providing the specimen (no exceptions).

(2) The use of mirrors is acceptable if the mirrors aid the collector in viewing the voiding process.

f. Unobserved Urine Specimen Collection Procedures

The vendor shall perform the following urine specimen collection procedures if circumstances prevent the observed collection of a specimen. Unobserved urine collection should be a rare occurrence and not a general manner of vendor operations. The vendor shall ensure that collectors:

(1) Take unobserved specimens only when the defendant/person under supervision and the collector are not of the same gender or it is virtually impossible to collect an observed specimen. If circumstances necessitate the collection of unobserved specimens, the vendor shall contact the CO

BPA-Solicitation Number: 0973-27-25 Page C- 7 of 40 for approval prior to the collection. If unobserved collection has not been approved, the vendor shall not invoice for the collection.

(2) Secure any source of water in the area where the collection occurs, by either shutting off the water or securing its access with tamper evident tape.

(3) Remove and/or secure any agents that could be used to adulterate the specimen, such as soaps, cleaners, and deodorizers.

(4) Clearly document on the Chain of Custody Form all unobserved collections and document and obvious signs of substitution or contaminants.

(5) When provided by the Designee, use a temperature strip to measure urine specimen temperatures which should range between 90- and 100-degrees Fahrenheit. The time from voiding to temperature measurement is critical and in no case shall exceed 4 minutes.

(6) Obtain a second specimen from defendant/person under supervision if the urine specimen temperature is outside the specified range. To prevent dilute specimens, limit fluid intake by the defendant/person under supervision to no more than 8 ounces per hour.

(7) Place a coloring agent in the commode to deter dilution of the specimen with commode water.

(8) Follow all general collection procedures in subsection d above.

g. Urine Specimen Mailing and Storage (For specimens shipped or transferred to contract national drug testing laboratories or on-site instrumented drug testing laboratories).

The vendor shall ensure that:

(1) Every specimen shipped or transferred to a testing facility is contained in a collection container specifically designed to withstand the rigors of transport. All collection containers shall be provided by the Designee.

(2) The collector places the specimen and corresponding Chain of Custody Form in the approved shipping container, notifies the shipper/delivery service/courier that specimen(s) are ready to be delivered to the laboratory, and places such containers in the custody of an approved delivery service or courier.

(3) Specimens shall be mailed/shipped no later than the close of

BPA-Solicitation Number: 0973-27-25 Page C- 8 of 40 business the day the specimens are collected, or the morning of the day following the collection.

(4) Urine specimens are stored in a secure area with access limited only to collectors or other vendor authorized personnel.

h. “No Test” Policy

The urinalysis laboratories under national contract with the Administrative Office of the U.S. Courts will only test urine specimens if all the following conditions are met.

(1) The specimen bottle contains no less than 10 milliliters of urine.

(2) The specimen security seal or tamper evident system (e.g., tape) is present and intact.

(3) The specimen bar code label is present.

(4) The specimen is accompanied by the Chain of Custody Form.

(5) The specimen identifier (i.e., bar code number) on the bottle is identical to the number on the Chain of Custody Form.

(6) The collector’s signature is on the Chain of Custody Form.

When any of the above conditions are not met, “No Test” will be stamped on the request report form and the reason for the no test will be checked or written in the space provided. Specimens that cannot be tested will be discarded. The vendor shall ensure that all the above conditions are present for specimens sent to the national drug testing laboratories and local or regional on-site laboratories. For districts using a local or regional on-site laboratory for testing of samples, the Chain of Custody Form shall also include the signature of the defendant/person under supervision.

For specimens that are received by the national drug testing laboratories or local or regional on-site laboratories and are untestable in accordance with the no-test policy or failure to follow the required collection guidelines, the vendor shall not invoice the district for the cost of the collection. The Designee will provide notification to the vendor of untestable specimens.

i. Random Urine Specimen Collection Procedures

The vendor shall provide random urine specimens collections in accordance with the following:

BPA-Solicitation Number: 0973-27-25 Page C- 9 of 40

(1) The vendor shall collect random urine specimens at the frequency determined and authorized in the Probation Form 45.

(2) The vendor shall collect random urine specimens when the defendants/person under supervision have less than 24 hours’ notice to submit a urine specimen.

(3) The vendor cannot change a randomly scheduled urine collection time and date without the advance approval of the CO.

(4) At the CO’s request, the vendor shall develop and operate an automated notification system for random urine collections, subject to the approval of the CO before use.

j. Urine Specimen Collection - Urinalysis Testing Log

The vendor shall utilize the Urinalysis Testing Log (included within Section J attachments) for all urinalysis specimens collected which shall indicate:

(a) Defendant/person under supervision’s name and PACTS number.

(b) Vendor name and agreement #

(c) Month/Year

(d) Collection Date

(e) Defendant’s/person under supervision’s signature

(f) Collector initials

(g) Bar Code number

(h) Special tests requested

(i) Drugs or medications taken, and

(j) Co-pay collected (if applicable)

Prior to the use of any other log to record this information, the vendor shall seek approval of the log from the CO.

NOTE: Allowing participants to see the names or signatures of defendants/person under supervision violates federal confidentiality regulations regarding disclosure of drug or alcohol treatment records.

k. National Contract Urinalysis Laboratories

Some initial urine specimens are analyzed under a separate national laboratory contract secured by the Administrative Office of the U.S. Courts. Any confirmation testing completed on urine specimens that have a presumptive positive result shall be done by the national contract testing laboratory. The Designee shall provide supplies and instructions for the shipping and handling of specimens.

BPA-Solicitation Number: 0973-27-25 Page C- 10 of 40

l. Onsite Screening Urinalysis Laboratory

Urine specimens are analyzed by onsite local or regional laboratories at some locations in Probation and/or Pretrial Services Offices. Specimens sent to these facilities shall be processed in the same manner as listed above. Upon award, the CO shall notify the vendor that it uses an on-site testing laboratory and provide supplies and instructions for the shipping and handling of specimens.

2. Sweat Patch Application and Removal (1012):

The sweat patch is a white absorption pad, covered with a polyurethane dressing that acts as a storage device for illicit drugs released from the body in sweat. Sweat patches are most often used for continuous and long-term drug testing for defendants/persons under supervision who have difficulty voiding due to documented medical conditions, when the vendor does not have same gender collection available, and/or for transgender individuals. Sweat patch supplies will be provided by the Judiciary; however, the vendor is responsible for the postage/shipping costs related to sending samples for analysis. If USPO/USPSO approves the vendor’s use of the sweat patch on the Probation Form 45, the vendor shall use the following procedures for the application, removal, and testing process of the sweat patch:

a. Staff Training

The vendor shall ensure that their staff is trained in the sweat patch procedures before applying or removing a patch. The staff should complete the authorized web-based sweat patch training (training link provided by the CO), take and pass the certification test provided by the sweat patch vendor, and perform the procedures contained in this section of the statement of work. The vendor shall document training for personnel it authorizes to apply and remove sweat patches.

This documentation must include a certificate from the sweat patch vendor which indicates a successful completion of the certification test.

The vendor shall ensure training includes fostering respectful and appropriate interactions with defendants/persons under supervision regardless of gender, race, ethnicity, religion, cultural background, sexual orientation, or other personal characteristics.

b. Storage

The vendor shall:

(1) Ensure patches are stored in a secure area with access limited to only collectors or other authorized vendor personnel.

(2) Ensure patches are stored at temperatures between 36- and 78-degrees Fahrenheit.

BPA-Solicitation Number: 0973-27-25 Page C- 11 of 40

c. Safety Precautions

The vendor shall:

(1) Ensure the integrity of the collection process and make every effort to eliminate the possibility of external contamination. Staff shall wear gloves while applying and removing the patch and avoid touching the collection pad during the process.

(2) If a witness is available, have a witness present when the defendant/person under supervision and the collector are of opposite gender.

d. Sweat Collection and Duration of Sweat Patch Use

The vendor shall:

(1) Ensure that the patch is worn for a minimum of 24 hours. The maximum wear time for the patch is 7 to 10 days, or up to 14 days with the use of an overlay.

(2) Follow notification protocols outlined in this Statement of Work under Notifying USPO/USPSO of Defendant/Person Under Supervision Behavior if a defendant/person under supervision reports with a sweat patch that is falling off, has fallen off, or is missing. In consultation and with approval of the USPO/USPSO, the vendor shall stop using a sweat patch on defendants/persons under supervision who continue to experience difficulties in retaining the patch on their skin.

e. Sweat Patch Application

The vendor shall follow the procedures demonstrated in the web-based sweat patch training and shall:

(1) Complete the left side of the sweat patch Chain of Custody form with the defendant/person under supervision name, PACTS #, and the sweat patch identification number (on the outside of the film of the sweat patch), the date the patch is applied, the observer initials, the defendant/person under supervision initials, test ordered, and reason for specimen.

(2) Advise the defendant/person under supervision the patch may be

BPA-Solicitation Number: 0973-27-25 Page C- 12 of 40 placed on the upper arm, the lower back, or the front kidney area.

Ask the defendant/person under supervision where they would prefer to have the patch applied. Apply the patch on the preferred location, but avoid placement on tattooed, abraded, cut, irritated or sensitive skin.

(3) Direct the defendant/person under supervision to clean the area with soap and cool water or with a disposable towelette. An abrasive pad may be used to clean dry skin and dirt.

(4) Wearing disposable gloves, the collector shall thoroughly clean the skin by using alcohol wipes. Repeat the cleansing if the wipe is dirty. Allow the area to dry for approximately 90 seconds to avoid alcohol burns to the skin.

(5) Have the defendant/person under supervision flex the upper arm for arm placement, bend forward slightly at the waist for back placement, or bend slightly backward at the waist for front kidney placement. Place the patch on skin and press firmly to promote proper adhesion. Pull parallel to the skin when removing the paper border, not outward and up from the patch. As the paper border is removed, follow right behind with a finger pressing on the polyurethane film.

(6) Instruct the defendant/person under supervision to remove a sweat patch if they experience a rash or any skin irritation, and immediately report the problem to the vendor and USPO/USPSO, or follow other notification protocol outlined by the CO.

(7) The observer shall sign the certification section on the left side of the sweat patch Chain of Custody form.

(8) Provide clear instructions as to the scheduling for removal of the patch.

f. Sweat Patch Removal

The vendor shall ensure that collectors follow the procedures demonstrated in the training video, particularly the following:

(1) Retrieve the original sweat patch Chain of Custody form completed at time of application and compare the sweat patch identification number written on the form with the number printed on the outside of the patch. If the numbers agree, wearing a new pair of

BPA-Solicitation Number: 0973-27-25 Page C- 13 of 40 disposable gloves, the observer shall peel back the top edge of the sweat patch sufficiently to expose the pad. The observer shall inspect the pad to ascertain whether there are any signs of tampering.

(2) To ensure the pad is not contaminated by the observer or the defendant/person under supervision, the pad shall be removed with a clean pair of single use disposable tweezers and immediately placed in the specimen bag.

(3) Affix the bar code sticker from the Chain of Custody form to the outside of the specimen bag and affix the security seal from the Chain of Custody form to seal the bag closed. Write the date the patch was removed on the security seal and initial it.

(4) Remove the outside film of the sweat patch and complete a visual inspection. If signs of tampering are evident, it should be noted on the Chain of Custody form. Do not include the outside film or overlay in the specimen bag with the absorbent pad. This will result in a no-test, and the vendor will not be reimbursed for the service.

(5) The observer shall complete the right side of the sweat patch Chain of Custody form with the removal date, observer’s initials, defendant/person under supervision initials, tamper statement, comment to include wear the patch was worn, and medications taken. The defendant/person under supervision and the observer shall sign the certification statements on the Chain of Custody.

(6) Place the completed Chain of Custody form into the transport bag along with the sealed specimen bag containing the absorbent pad.

(7) Ensure the specimen is kept at room temperature in a secured area and mailed or shipped within 24 hours to the laboratory for analysis. The vendor is responsible for postage/shipping costs related to sending samples for analysis.

(8) Provide the defendant/person under supervision clear instructions on when to report for reapplication, if applicable.

g. Sweat Patch Test Policy

A laboratory will only test sweat patches if all the following conditions are met:

(1) The absorption pad is accompanied by a Chain of Custody Form

BPA-Solicitation Number: 0973-27-25 Page C- 14 of 40 signed and completed by the collector.

(2) The absorption pad is in a specimen bag, and the security seal shall be present, initialed by collector, and intact.

(3) A barcode label is present on the specimen bag and a security seal is present and intact.

(4) The sweat patch number on the polyurethane film shall match the sweat patch number on the Chain of Custody Form.

h. Sweat Patch Testing Log

The vendor shall:

Utilize the Sweat Patch Testing Log (included within the Section J attachments) which includes the following information:

a. the name of the defendant/person under supervision,

b. PACTS Number,

c. Chain of Custody barcode number,

d. medications taken,

e. application date,

f. removal date,

g. test result,

h. observer’s initials,

i. co-pay collected (if applicable), and

j. a place to note any unusual occurrences.

Use of any other logs must be approved by the CO.

i. Sweat Patch Invoicing

The vendor shall:

(1) Invoice one price for all elements in the sweat collection process.

(2) Not invoice if the defendant/person under supervision fails to return for removal of the patch, if the defendant/person under supervision loses the patch, or if the laboratory refuses to test the sweat patch because the conditions in paragraph “g” of this section were not satisfied.

(3) Invoice for the service during the month the patch is removed.

Services should not be invoiced if only application occurs.

BPA-Solicitation Number: 0973-27-25 Page C- 15 of 40

(4) Include each Sweat Patch Testing Log with the invoice.

3. Breathalyzer (1504):

The vendor shall:

a. Provide a breath alcohol content (BAC) test and all supplies and consumables necessary to operate the instrument, in accordance with the Probation Form 45. The vendor shall provide and use a reliable instrument approved by the CO.

b. Ensure all staff using the instrument are trained and familiar with its operation as outlined in the manufacturer’s operation instructions, and their training is documented.

c. Report a positive BAC test, no show, or refusal of the defendant/person under supervision to take the BAC test to the USPO/USPSO within 24 hours.

d. Utilize the Breathalyzer Log (included in the Section J attachments) to indicate those defendants/persons under supervision tested, the staff performing the test, the reason for the test, the test results, additional comments, to include refusal by the defendant/person under supervision. Use of any other log shall be approved by the CO.

e. Maintain an instrument log (included in the Section J attachments) that will document the instrument’s serial number, requirements for calibration, dates of calibration, and the date for the next calibration. Use of any other Instrument logs shall be approved by the CO.

SUBSTANCE USE SERVICES

4. Case Management Services (Substance Use) (2000)

Case Management Services (Substance Use) is defined as a method of coordinating the individualized care and services of drug and/or alcohol dependent people and is most often utilized in Re-entry/Specialty Courts. Case management services serve as a way of tailoring and linking defendants/persons under supervision to essential services, including but not limited to securing financial benefits, health insurance, health and substance use services. This includes assessing the individual’s needs, planning, and securing appropriate services, monitoring progress, and providing support to ensure effective treatment. This service is generally used in conjunction with individual or group counseling (Project Codes 2010, 2020, 2022, 2030, 2040, 2090, 6015, 6026, 6027, 6036).

BPA-Solicitation Number: 0973-27-25 Page C- 16 of 40

The vendor shall provide:

Case Management Services (Substance Use) (2000) to defendants/persons under supervision which may include but is not limited to:

(1) Intensive community-based services to maximize the defendant’s/person under supervision’s access to services and ability to function in the community.

(2) Facilitating service linkage in the community and coordinating integrated services from multiple providers, and monitoring progress (where applicable).

(3) Supportive/problem-solving individual counseling.

(4) Direct service support including assistance with obtaining transportation, housing, financial aid, including but not limited to Medicaid and Medicare, coordinating team meetings, filing application for services (including Social Security and other local assistance programs), escort to appointments, medication compliance, and daily living skill remediation.

(5) Skill-teaching to families.

(6) Crisis intervention.

(7) Attend Re-entry/Specialty Court proceedings and provide verbal and written reports on the defendant’s/person under supervision’s progress as required by the Court, when applicable (see additional requirements under the Local Services Section).

5. Substance Use Assessment (2011)

Treatment for drug use depends on the type of drug and the severity of abuse as well as other factors specific to the individual. The Substance Use Assessment is a comprehensive biopsychosocial assessment and report which shall be conducted by a practitioner who adheres to the standards of practice established by their state’s regulatory board. This ensures the practitioner adheres to the highest level of professional conduct, maintains current certification or licensure, and provides services that align with regulatory guidelines and ethical standards.

The substance use assessment should include the following key components:

Presenting Concerns: The main reason for the assessment, including specific concerns related to substance use.

Substance Use History and Assessment of Current Needs: Detailed historical and current information about the type, amount, frequency, and duration of substance use, as well as current daily functioning and the severity of symptoms.

Mental Health History and Assessment of Current Needs: Detailed historical and current information about diagnosis, symptoms and severity, hospitalizations, prescribed medications, and adherence.

BPA-Solicitation Number: 0973-27-25 Page C- 17 of 40

History of Trauma and Assessment of Current Factors Affecting Treatment:

Use reliable and validated trauma-informed screening and assessment tools to assess the individual’s trauma related symptoms and disorders to accurately identify and match appropriate treatment interventions. Examples of screening instruments include but are not limited to: Clinician Administered PTSD Scale for DSM (CAPS-5), Global Psychodrama Screen (GPS), Trauma History Questionnaire (THQ), Trauma Screening Questionnaire (TSQ), Brief Trauma Questionnaire (BTQ), and Life Events Checklist for DSM-5 (LEC-5). Should trauma-related symptoms be identified, the vendor should identify trauma-specific treatment interventions that emphasize empowerment and recovery.

Risk Assessment: Assessment of risk of harm to self or others, including information related to historical suicidal ideation and gesturing, and/or homicidal ideation.

Cultural and Spiritual Factors: Assess the individual’s identified cultural background and spiritual beliefs that may influence effective treatment interventions.

Medical History: Consider relevant medical conditions, treatments, and medications that may impact the individual’s current functioning and any potential impact on treatment.

Assessment Tools and Results: Results from validated and standardized screening and assessment tools used during the assessment which may include but are not limited to: SBIRT, ASI, SASSI, LSI-R, and DAST.

Strengths and Resources: Identify protective factors that support recovery such as strong familial and/or social support, positive self-perception, consistent coping skills, safe and stable housing, education and/or employment stability.

Readiness to Change: The individual's stated willingness and motivation to engage and participate in the recommended treatment.

Detailed Treatment Recommendations: Provide detailed recommendations specific to the individual’s risk, needs, and circumstances as identified by diagnostic tools, clinical interviews, and collateral information, and when applicable, the PCRA. Treatment recommendations should include diagnoses consistent with the DSM or ICD. Clearly outline the primary issues to be addressed in treatment and the appropriate level of care needed (e.g., early intervention, outpatient treatment, inpatient). Specify the recommended frequency/dosage and type of service (e.g., individual, group) appropriate to address the identified treatment needs of the individual.

If treatment is not recommended, provide detailed information about available community support systems and resources that may benefit the individual. These resources should be tailored to meet the individual’s specific needs, ensuring they receive appropriate support even in the absence of formal treatment recommendations.

BPA-Solicitation Number: 0973-27-25 Page C- 18 of 40

Within 15 business days of receiving the referral, any time frame exceptions shall be approved by the CO and documented by the vendor (within the defendant/person under supervision file), the vendor shall provide:

(a) A comprehensive diagnostic interview for each defendant/person under supervision, to include a validated, structured diagnostic instrument, that is in accordance with state licensing standards. The vendor shall also take into consideration the biopsychosocial information shared by the USPO/USPSO, to include criminal history and personal characteristics.

(b) A typed report to the USPO/USPSO within 10 business days of the vendor’s completion of the diagnostic interview with the defendant/person under supervision. At a minimum, the assessment report shall address the following:

(1) Basic identifying information, sources of the information for the report, and names of the diagnostic instrument and trauma screening assessments used.

(2) DSM or ICD diagnosis including severity of the substance use disorder (mild, moderate, severe).

(3) A biopsychosocial profile of symptoms that are related to substance use and mental health diagnoses, if applicable.

(4) The current level of functioning and the primary focus of the initial treatment plan.

(5) Current risk, need, responsivity factors as indicated by the PCRA (for post-conviction cases when provided by USPO),

(6) The defendant’s/person under supervision’s stated willingness and motivation to engage in treatment and make changes, and

(7) A treatment recommendation outlining suggestions for treatment option, interventions, and follow-up care.

Recommendations shall include the appropriate level of care, frequency/dosage, and type of service (e.g. individual, group, etc.).

The comprehensive assessment report shall not be a synopsis or overview of any presentence, pretrial or institutional progress reports provided by the

USPO/USPSO.

BPA-Solicitation Number: 0973-27-25 Page C- 19 of 40

6. Manualized Cognitive Behavioral Group

Cognitive Behavioral Therapy focuses on identifying and changing inaccurate or distorted thinking patterns, emotional responses, and behaviors, while strengthening pro-social skills.

For USPO referrals, this type of intervention shall be used in addressing criminogenic risk and needs in accordance with the person under supervision’s PCRA results.

The vendor shall provide:

Manualized Cognitive Behavioral Group (2022) to two (2) or more defendants/persons under supervision but no more than twelve (12) led by a trained facilitator as defined below. The groups shall offer a structured approach to a specific component of an intervention plan and address the criminal thinking component of a defendant/person under supervision. If a specific curriculum has not been identified in the Local Services section, the specific curriculum utilized by the vendor must be designed for criminal justice involved defendants/persons under supervision to address substance use and criminal thinking and must be approved in advance by the contracting officer or designee.

The applicable course materials shall be provided by the vendor and included in the price for this service. In the event the defendant/person under supervision misplaces a copy of the applicable course materials, the vendor is required to provide one additional copy of the materials at no…